Attached files
file | filename |
---|---|
EX-31.2 - EXHIBIT 31.2 - Akari Therapeutics Plc | v434647_ex31-2.htm |
EX-21.1 - EXHIBIT 21.1 - Akari Therapeutics Plc | v434647_ex21-1.htm |
10-K - 10-K - Akari Therapeutics Plc | v434647_10k.htm |
EX-23.1 - EXHIBIT 23.1 - Akari Therapeutics Plc | v434647_ex23-1.htm |
EX-31.1 - EXHIBIT 31.1 - Akari Therapeutics Plc | v434647_ex31-1.htm |
Exhibit 32
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Akari Therapeutics, Plc, a corporation organized under the laws of England and Wales (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2015 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: March 23, 2016 | /s/ Gur Roshwalb |
Chief Executive Officer | |
Principal Executive Officer | |
Dated: March 23, 2016 | /s/ Dov Elefant |
Chief Financial Officer | |
Principal Financial Officer |